Immunotherapy for pulmonary squamous cell carcinoma and colon carcinoma with pembrolizumab: A case report

AbstractRationale:Novel treatment strategies such as immunotherapy are being evaluated to further improve the outcomes of colorectal cancer patients. To our knowledge, this is the first report to show both the successful treatment of pulmonary squamous cell carcinoma (SCC) with pembrolizumab alongsi